Expertise in
2
conditions

Philippe Rieu

Reims, FR 
Expertise in
2
conditions
Reims, FR 
OverviewLocationsClinical Research

Overview

Philippe Rieu practices in Reims, France. Mr. Rieu is highly rated in 2 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, High Potassium Level, Polycystic Kidney Disease, Kidney Transplant, and Nephrectomy.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Reims, France
Other Locations
Grenoble, 38054, France
Argenteuil, France
Sarcelles, France
Amiens, France
CHU Strasbourg, Dialysis and Renal Transplantation
Strasbourg, France
Dialysis and Renal Transplantation
Besancon, 25000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria
Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria
Enrollment Status: Withdrawn
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drugs: ADV7103, Standard of Care
Study Phase: Phase 2/Phase 3
ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST), Phase III b
ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST), Phase III b
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Drug
Study Drug: Spironolactone
Study Phase: Phase 3
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2023
Intervention Type: Drug
Study Drug: Eplerenone
Study Phase: Phase 3
View 2 Less Clinical Trials

71 Total Publications

Impact of SGLT2 inhibitors on blood pressure among kidney transplant recipients: insights from a French multicentric cohort (GREAT ASTRE).
Impact of SGLT2 inhibitors on blood pressure among kidney transplant recipients: insights from a French multicentric cohort (GREAT ASTRE).
Journal: Clinical hypertension
Published: April 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rieu's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile